Date: 2012-10-30
Type of information: Distribution agreement
Compound: KEM® data analytics software and services technology
Company: Ariana Pharma (France) CTC Laboratory Systems Corporation - CTCLS (Japan)
Therapeutic area:
Type agreement: distribution
Action mechanism: Ariana’s KEM®, or Knowledge Extraction and Management, is a novel, association rules-based (non-statistical) data-analytical technology that finds patient responder sub-populations and biomarker signatures that statistical methods are unable to detect. In the life science industry, KEM saves sponsors both time and money by optimizing clinical trial inclusion/exclusion criteria thereby lowering the number of patients needed to reach clinical endpoints.
Disease:
Details: Ariana Pharma, the premium provider of advanced, non-statistical clinical data and biomarker analytics technology across life science industries as well as the FDA, has announced the signing of an exclusive Japanese distribution agreement with CTC Laboratory Systems Corporation (CTCLS), the Japanese supplier of services for R&D solutions. CTCLS will distribute Ariana’s KEM® data analytics software and services technology to Japanese markets. Ariana selected CTCLS as its Japanese distribution partner because of the company’s dominant presence in Japan. This deal with CTCLS will provide Ariana Pharma an excellent entry into Asia and the world\'s third largest biotechnology market.
Financial terms:
Latest news:
